The Broker Innovation Lab celebrates brokers and other benefits stakeholders who have embraced the changing marketplace to position themselves and their business for future success
A provision in Congress's opioid bill expands the FDA's power to “debar” people “from importing or offering for import" drugs under certain circumstances.